NCT00005792
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,662 public trials
323 recruiting studies
Multiple Myeloma trial results
NCT00761722
- Conditions
- Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +26 more
- Locations
-
- California Cancer Care Inc Greenbrae, California, United States
- Main Cancer Centers of Florida, P.A. Ocoee, Florida, United States
- Indiana University School of Medicine Indianapolis, Indiana, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
NCT02811978
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beijing, China
- Chengdu, China
- Chongqing, China
- Fuzhou, China
NCT03046329
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
NCT01541644
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States
NCT00834665
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Greenbaum Cancer Center Baltimore, Maryland, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
NCT01142232
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- IU Simon Cancer Center Indianapolis, Indiana, United States
Completed
Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
NCT00657488
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hopital St Joseph Gilly, Belgium
- UCL de Mont Godine Yvoir, Belgium
- Chu D'Angers - Medecine D Angers, France
- Centre Hospitalier D'Annecy - Service d'oncohématologie Annecy, France
Completed
A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)
NCT01602224
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fullerton, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Barbara, California, United States
NCT00948922
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- H. Lee Moffitt Cancer Center Tampa, Florida, United States